ARWR
#845
Arrowhead Pharmaceuticals, Inc. - Common Stock
81.3 2 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.23%
Variación mensual
-2.76%
Variación en los últimos 6 meses
+32.06%
Cambio anual
+107.98%
Cierres anteriores
84.9 1
Open
81.3 5
Mínimo
80.7 6
Máximo
81.4 8
Volumen
326
Financials
- Market Capitalization 11.49 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-37.39
Relación precio/flujo de caja
16.85
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 815 |  CORT Corcept Therapeutics Incorporated - Common Stock | 112.95 USD | -0.82% | -7.65% | -1.06% | +53.95% | 12.21 B USD | ||
| 817 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 106.22 USD | +0.83% | -1.26% | +28.60% | +59.01% | 12.06 B USD | ||
| 850 |  TECH Bio-Techne Corp - Common Stock | 72.32 USD | -0.04% | -0.04% | +0.25% | +33.51% | 11.34 B USD | ||
| 871 |  SMMT Summit Therapeutics Inc. - Common Stock | 13.55 USD | -1.31% | +7.11% | +4.63% | -31.77% | 10.81 B USD |